Peter M. Pushko
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$2.0MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Mar 18, 2021 | NIH | SBIR Phase I Novel Chikungunya vaccine with rearranged genome | $120K | MEDIGEN, INC. |
| Apr 3, 2020 | NIH | SBIR Phase I Novel Chikungunya vaccine with rearranged genome | $121K | MEDIGEN, INC. |
| Mar 4, 2019 | NIH | SBIR Phase I Multivalent emergency vaccine against pandemic influenza | $95K | MEDIGEN, INC. |
| Jan 27, 2017 | NIH | SBIR Phase II Novel DNA-Launched Attenuated Vaccine for VEE Virus SBIR Phase II | $813K | MEDIGEN, INC. |
| Jan 27, 2016 | NIH | SBIR Phase II Novel DNA-Launched Attenuated Vaccine for VEE Virus SBIR Phase II | $812K | MEDIGEN, INC. |
Peer ranks
Federal funding#1,076
Awards as PI#417
Patents#273
Companies
- MEDIGEN, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.